|
|
.
See Category: Diseases of the genitourinary system
ICD-10 (CM) Code and Descriptor
|
N39.3 |
Stress incontinence (female) (male)
|
N393 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 32.52%
|
24.32%
|
13.82%
|
8.50%
|
5.41%
|
3.77%
|
2.86%
|
2.07%
|
1.64%
|
1.18%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N39.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
97110
|
THERAPEUTIC EXERCISES |
13,725
|
26,957
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
9,308
|
9,322
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
8,666
|
15,187
|
|
J3010
|
FENTANYL CITRATE INJECTION |
7,078
|
12,489
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
6,733
|
178,654
|
|
J2405
|
ONDANSETRON HCL INJECTION |
6,711
|
28,915
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
5,926
|
15,812
|
|
97530
|
THERAPEUTIC ACTIVITIES |
5,893
|
9,278
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
5,104
|
22,142
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
4,876
|
31,792
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
4,635
|
7,260
|
|
C1771
|
REP DEV, URINARY, W/SLING |
4,610
|
4,648
|
|
57288
|
REPAIR BLADDER DEFECT |
4,423
|
4,423
|
|
87086
|
URINE CULTURE/COLONY COUNT |
4,134
|
4,139
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
3,628
|
17,323
|
|
J7120
|
RINGERS LACTATE INFUSION |
3,608
|
5,025
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
3,575
|
3,595
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
3,464
|
7,052
|
|
97535
|
SELF CARE MNGMENT TRAINING |
3,085
|
4,241
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
2,890
|
2,896
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N39.3 related to the following DRG Codes:
695-696
742-743
760-761
|
